Cytotoxic effects of the combined use of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger and an approved medicine for acute brain infarction in Japan, with a pterin derivative, were examined in vitro. When pancreatic cancer cell line Panc-1 cells were incubated with 50 to 400 M of a pterin derivative, 2-(N,N-dimethylaminomethyleneamino)-6-formyl-3-pivaloylpteridine-4-one (DFP), and the equivalent dose of edaravone, reactive oxygen species (ROS), were generated, and cell death was induced. ROS generation and the loss of mitochondrial membrane potential (MMP) preceding cell death were simultaneously monitored using time-lapse microscopy with an ROSsensitive dye and a probe to monitor MMP, respectively. Cell death was also estimated quantitatively by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. ROS generation and cell death were prominent when more than 100 M of each agent was used in combination, whereas the sole use of each agent did not show any effects even at the highest dose, 400 M. Chemical analysis revealed that DFP and edaravone react immediately in aqueous solution and produce a new compound named DFP-E. DFP-E chemically reacted with NADH much faster than DFP and generated ROS, and biologically, it was much more cell-permeable than DFP. These findings collectively indicated that the combined use of DFP with edaravone produced DFP-E, which caused intracellular ROS generation and cell death. Cell death was observed in normal cells, and edaravone reacted with another pterin derivative to yield an ROS-generating compound. As a result, care should be taken with the clinical use of edaravone when pterin derivatives stay in the body.
2005). It is controversial whether edaravone scavenges superoxide anion (O 2
•Ϫ ) or not Wu et al., 2000) . In a recent study, we demonstrated that edaravone scavenged singlet oxygen ( 1 O 2 ) released from activated human neutrophils with an IC 50 of 0.3 M and suggested that this potent 1 O 2 scavenging activity of edaravone might be involved in its curative effects on acute brain infarction .
Singlet oxygen is known to induce neuronal and hepatic cell death (Cutrìn et al., 2000; Petrat et al., 2003; Valencia and Moran, 2004) . Furthermore, 1 O 2 is tumoricidal and plays an important role in anticancer photodynamic therapy (Dougherty et al., 1998; Dolmans et al., 2003) . In the previous study, we showed that a pterin derivative, 2-(N,N-dimethylaminomethyleneamino)-6-formyl-3-pivaloylpteridine-4-one (DFP; Fig. 1, right) , generated a large amount of 1 O 2 under long-wavelength UV light (UV-A), which induced cell death in a pancreatic cancer cell line, Panc-1 cells . That is, we showed the photodynamic effects of DFP on Panc-1 cells. Because the cell death was induced by generated 1 O 2 , and edaravone was a potent 1 O 2 scavenger, we applied both edaravone and DFP to Panc-1 cells anticipating that edaravone would attenuate the cell death induced by photodynamic effects of DFP; however, unexpectedly, edaravone enhanced cell death, and further, cell death was induced, regardless of UV-A irradiation (data not shown). This finding led us to conceive the idea that DFP reacts with edaravone and generates a highly toxic new compound even when the concentration of each agent is far from a toxic dose. Furthermore, since we documented that DFP generates ROS through NADH oxidation (Nonogawa et al., 2007) , the ROS generation is considered to be involved in this phenomenon.
In the present study, to verify the above-mentioned idea, the reaction of DFP with edaravone was analyzed chemically, and the effects of their combined use were examined biologically. For that purpose, production analysis of the reaction of DFP with edaravone was performed, and the chemical characters and activities of the reaction product were examined. The effects of the combined use of DFP with edaravone on cell viability and intracellular ROS generation were also examined in Panc-1 cells. Furthermore, the effects of the combined use of DFP with edaravone were examined in normal cells, such as human umbilical vein endothelial cells (HUVECs) and primary cultured rat hepatocytes. Furthermore, it was examined whether edaravone reacted with another pterin derivative to yield an ROS-generating compound.
Materials and Methods
Reagents. Edaravone was a kind gift from Mitsubishi Pharma Corporation (Tokyo, Japan). DFP was synthesized in our laboratory from 6-formylpterin (6FP) according to the procedure described previously (Nonogawa et al., 2006) . 6FP was obtained from Sankyo Kasei Kogyo (Hiratsuka, Japan). Dulbecco's modified Eagle's medium for Panc-1 cells, RPMI 1640 medium for hepatocytes, fetal calf serum (FCS), and penicillin-streptomycin liquid were purchased from Invitrogen (Carlsbad, CA). Humedia-EG2 complete medium for HUVECs was obtained from KURABO (Osaka, Japan). 2Ј,7Ј-Dichlorofluorescein diacetate (DCFH-DA) and tetramethylrhodamine methyl ester (TMRM) were obtained from Molecular Probes (Eugene, OR). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and diethylenetriaminepentaacetic acid (DETAPAC) were from Nacalai Tesque (Kyoto, Japan). 5,5-Dimethyl-1-pyrroline-Noxide (DMPO) was from Labotec Co. (Tokyo, Japan). Other chemicals, such as catalase and N-acetyl-L-cysteine (NAC), were purchased from Sigma Chemicals (St. Louis, MO).
Preparation of Working Solutions of DFP and Edaravone. Both DFP and edaravone were directly dissolved in phosphate-buffered saline (137 mM sodium chloride, 8.1 mM sodium phosphate dibasic, 2.68 mM potassium chloride, and 1.47 mM potassium phosphate monobasic, PBS) to a final concentration of 4 mM in each, pH 7.4, and filtered for sterilization.
Purification of the Reaction Product of DFP with Edaravone. The PBS solution containing 4 mM DFP and that containing 4 mM edaravone were mixed with stirring for 2 h at room temperature. During this time, precipitation appeared and was separated by centrifugation, and then dried by freezing. The resultant solid was purified by a high-performance liquid chromatography (HPLC) system consisting of an L-6200 pumping system and an L-4000 UV detector (HITACHI, Ibaraki, Japan); column, ULTRON VX-SIL (Shinwa Chemical Industries, Kyoto, Japan); column and particle size, 20.0 ϫ 250 mm and 5 m, respectively; and eluent, CHCl 3 -MeOH (60:40). The fraction was evaporated in vacuo, and the compound was obtained as a yellow solid, which was named reaction product of DFP with edaravone (DFP-E).
Structure Analysis and Water Solubility of DFP-E. To determine the chemical structure of DFP-E, 1 H and 13 C NMR spectra of DFP-E were recorded on a JEOL ECA-600 NMR spectrometer (JEOL Ltd., Tokyo, Japan) operating at 600 and 150 MHz, respectively, in deuterated dimethyl sulfoxide. All chemical shifts are reported in parts per million down field from tetramethylsilane. Peak multiplicities are denoted by broad (br), singlet (s), broad singlet (br s), and broad doublet (br d). Mass spectra of DFP-E were recorded on a JEOL DX-300 at 30 eV as electron impact condition. The water solubility of DFP-E was determined by UV spectroscopy.
Test of DFP-E Stability. To examine the stability of DFP-E, four types of PBS solutions were prepared as follows: PBS containing 300 M DFP and 300 M edaravone (1:1), PBS containing 300 M DFP and 600 M edaravone (1:2), PBS containing 300 M DFP and 900 M edaravone (1:3), and PBS containing 300 M DFP and 1200 M edaravone (1:4). These solutions were allowed to stir in an open system at room temperature. After 30 min and 20 h, DFP-E concentrations were measured by reversed-phase (RP)-HPLC as described below.
Production Analysis of the Reaction of DFP alone, Combination of DFP and Edaravone, or DFP-E with NADH. Production analysis of the reaction of DFP, combination of DFP and edaravone, or DFP-E with NADH was performed using RP-HPLC. Three types of PBS solutions were prepared as follows: PBS containing 300 M DFP and 300 M NADH; PBS containing 300 M DFP, 300 M edaravone, and 300 M NADH; and PBS containing oversaturated DFP-E and 1 mM NADH. These solutions were allowed to stir in an open system at room temperature. The time-dependent concentration change of each component in the sample solution was analyzed by RP-HPLC. NAD ϩ in the RP-HPLC peak was identified by UV absorption spectra and quantified by RP-HPLC again. The RP-HPLC system consisted of a DP-8020 pumping system, a CO-8020 column oven, and a PX-8020 system controller (TOSOH; Tokyo, Japan); column, ULTRON VX-ODS (Shinwa Chemical Industries); column and particle size, 4.6 ϫ 150 mm and 5 m, respectively; eluent, 10 mM; 100 mM triethylammonium acetate buffer (100 mM triethylamine and 100 mM acetic acid, pH 7.0); gradient, CH 3 CN concentration in the liner gradient mode (0 min, 0%; 30 min, 50%); flow rate, 1.0 ml/min; and temperature, 37°C. UV spectra were recorded on a Jasco UV/VIS Spectrophotometer V-550 (Japan Spectroscopic Co., Tokyo, Japan).
To examine whether edaravone reacted with another pterin derivative that may exist in vivo, reaction of 6FP alone or combination of 6FP and edaravone with NADH was also examined using the RP-HPLC system. Because 6FP is poorly soluble in water at neutral pH, 6FP solutions were prepared by diluting 20 mM 6FP in 0.1 N NaOH solutions with PBS.
Oxygen Electrode Measurements. To confirm O 2 consumption during the reaction of NADH with DFP alone or combination of DFP and edaravone, O 2 concentrations of reaction solutions were measured polarographically with a Clarke oxygen electrode (model 5300; Yellow Springs Instruments, Yellow Springs, OH) at 37°C in 4 ml of reaction mixture. Oxygen concentration was calibrated with airsaturated PBS, which was assigned as 100%.
Electron Paramagnetic Resonance Spectroscopy and Spin Trapping. To determine whether the reaction of DFP-E with NADH produces ROS, an electron paramagnetic resonance (EPR) spectroscopy with a spin trap, DMPO, was used to directly measure oxygen radicals. PBS solution containing 1 mM DFP-E, pH 10, and 2 mM NADH were allowed to stir for 48 h at room temperature. After the addition of 100 mM DMPO, 500 M DETAPAC, and 250 M FeSO 4 , the mixture was transferred to a flat quartz EPR aqueous cell, which was fixed in the cavity of the EPR spectrometer. EPR spectra were recorded on a Model JES-TE300 spectrometer (JEOL Ltd., Tokyo, Japan). EPR settings were as follows: microwave power, 5 mW; field, 329.4 Ϯ 5 mT (9.2533 GHz); modulation, 0.079 mT; time constant, 0.03 s; amplitude, 500; and sweep time, 1 min. The intensity of DMPO spin adducts and hyperfine splitting constants were calculated, based on the Mn 2ϩ marker, which was inserted into the cavity of the EPR spectrometer.
ROS formation in cells was also verified using EPR spectroscopy. Panc-1 cells, cultured as described below, were incubated with 400 M DFP alone or combination of 400 M DFP and 400 M edaravone for 4 h in an FCS-free medium; FCS was omitted because of possible quenching of ROS. Then, the mixture of the supernatant of the cells with 100 mM DMPO, 500 M DETAPAC, and 250 M FeSO 4 was prepared and transferred to a flat quartz EPR aqueous cell, which was fixed in the cavity of the EPR spectrometer. EPR settings were modified as follows: microwave power, 10 mW; field, 329.3 Ϯ 5 mT (9.2535 GHz); modulation, 0.125 mT; time constant, 0.03 s; amplitude, 790; and sweep time, 2 min.
Emission of Fluorescence from Aqueous Solutions of DFP and DFP-E.
The pterin family emit fluorescence under UV-A radiation (wavelength around 360 nm) (Thomas et al., 2002) . Therefore, if the emission intensity is enough to detect, the uptake of DFP or DFP-E by cells should be observed using fluorescent microscopy with a UV filter. So, as a basic study, the emission of fluorescence from a 10 M concentration of the aqueous solution of DFP or DFP-E was scanned using a spectrofluorometer (F-4500; HITACHI) at a fixed excitation wavelength of 360 nm and a variable emission wavelength.
Cell Culture. Panc-1 cells were obtained from the American Type Culture Collection (Rockville, MD) and cultured in Dulbecco's modified Eagle's medium containing 10% FCS, 100 units/ml penicillin, and 100 g/ml streptomycin at 37°C in a 5% CO 2 incubator. HUVECs were obtained from KURABO and cultured in Humedia-EG2 complete medium. Third passage cells were used. Hepatocytes were isolated from male Wistar rats as previously described (Ishii et al., 2005) and cultured in RPMI 1640 medium containing 10% FCS, 100 units/ml penicillin, and 100 g/ml streptomycin. Primary cultured cells were used.
Uptake of DFP or DFP-E by Cells. To evaluate the uptake of DFP or DFP-E by Panc-1 cells, after incubation with DFP alone or combination of DFP and edaravone for 4 h, the cells were washed twice with PBS. The cells were then observed with a Nikon TE200 fluorescence microscope (Nikon, Tokyo, Japan) equipped with a LEICA DC500 digital charge-coupled device camera (Leica, Wetzlar, Germany) and a PC. To obtain visually clear contrast, the concentrations of DFP and edaravone were adjusted to 400 M.
Time-Lapse Cell Imaging. Intracellular ROS generation and cell death in Panc-1 cells were observed using a time-lapse imaging system (BioStation IM; Nikon), which consists of an incubator incorporating fluorescent microscopy equipped with a digital charge-coupled device camera and a PC for data acquisition and analysis. Cells (1 ϫ 10 5 cells/ml) were incubated overnight in a 35-mm glass base dish (IWAKI, Funabashi, Japan) in 2 ml of medium. The cells were then incubated with 100 nM TMRM, a mitochondrial membrane potential-sensitive dye (Petrat et al., 2003) , for 20 min. The medium was then changed, and the cells were incubated with combination of DFP and edaravone and 2 M DCFH-DA, an ROS-sensitive dye (Royall and Ischiropoulos, 1993) at 37°C and 5% CO 2 in the timelapse imaging system, and the phase-contrast images and fluorescent images were acquired every 15 min for 4 h. Green fluorescence images for DCF and red fluorescence images for TMRM were acquired using fluorescein isothiocyanate and tetramethylrhodamine B isothiocyanate filters (Nikon), respectively. The concentrations of DFP and edaravone were adjusted to 200 M because the changes in fluorescence were visually weak when 100 M DFP and edaravone were used, and rapid cell death and detachment interfered with visual observation when 400 M DFP and edaravone were used. Time-lapse imaging of cells incubated without DFP or edaravone was also performed.
Cytotoxicity Assessment. Panc-1 cells (1 ϫ 10 5 cells/ml) were incubated overnight in 12-well tissue culture plates (BD Biosciences, Bedford, MA) with 1 ml in each well. The cells were then incubated with DFP alone, edaravone alone, or combination of DFP and edaravone for 1, 2, 3, 4, or 24 h. After washing twice with PBS, the cells were incubated with fresh medium for another 24 h, except for the cells incubated with drugs for 24 h. Cell viability 24 h after medium change was assessed by the mitochondrial-dependent reduction of MTT to formazan (MTT assay). As for the cells incubated with drugs for 24 h, as soon as the cells were washed twice with PBS, cell viability was assessed by MTT assay. Effects of NAC, an antioxidant, on cell viability were also examined in cells incubated with a combination of DFP and edaravone.
HUVECs (5 ϫ 10 6 cells/ml) were incubated overnight in 12-well tissue culture plates with 1 ml in each well. The cells were then incubated with DFP alone or combination of DFP and edaravone for 4 h. After washing twice with PBS, the cells were incubated with Paradoxical ROS Generation by the Use of a Radical Scavenger 531 at ASPET Journals on July 8, 2017 jpet.aspetjournals.org fresh medium for another 24 h. Cell viability 24 h after medium change was assessed by MTT assay.
Hepatocytes (1.25 ϫ 10 5 cells/ml) were incubated overnight in 100-mm tissue culture dishes with 10 ml in each dish. The cells then were incubated with DFP alone or combination of DFP and edaravone for 4 h. After washing twice with PBS, the cells were incubated with fresh medium for another 24 h. Cell viability 24 h after medium change was assessed by MTT assay.
Statistical Analysis. Values are shown as the means Ϯ S.D. Statistical comparisons were made using one-way analysis of variance followed by Student's paired t test with Bonferroni correction. P values Ͻ 0.05 were regarded as significant.
Results

Chemical Structure and Water Solubility of DFP-E.
When PBS solution containing 4 mM DFP was mixed with PBS solution containing 4 mM edaravone, the precipitation of DFP-E appeared immediately. The precipitation was separated and then purified by HPLC. DFP-E was obtained as a yellow solid. From mass analysis, fractions of m/z 660, 486, 402, and 297 were observed for the electron impact condition, which indicated that the molecular mass of DFP-E was probably 660. 158.5, 158.4, 154.9, 153.8, 153.0, 146.3, 128.8, 128.1, 125.5, 120.4, 100.7, 43.3, 41.2, 35.3, 34.5, 27 .4, and 13.8. Proton peak of the 6-formyl group on DFP disappeared, although other proton signals of DFP remained. From these observations, we presumed that edaravone reacted with the 6-formyl group moiety on DFP to give DFP-E; however, we could not identify the exact chemical structure of this compound due to the complexity of the NMR spectra. Further investigations for identification are in progress in our laboratory. Water solubility determined by UV spectroscopy was approximately 200 M, when the molecular mass of DFP-E was assumed to be 660.
Stability of DFP-E. When PBS solution containing an equivalent amount of DFP and edaravone was employed, the DFP-E concentration was constant for 20 h. On the other hand, when PBS solutions containing DFP and excess amounts of edaravone were employed, DFP-E concentrations decreased during 20 h (data not shown). These findings indicated that surplus edaravone discomposed DFP-E. For this reason, equivalent concentrations of DFP and edaravone were always used for the following studies.
Reaction of DFP, Combination of DFP and Edaravone, or DFP-E with NADH. When PBS solutions containing 300 M DFP and 300 M NADH were allowed to stir for 100 h, the oxidation of NADH to NAD ϩ occurred at a slow rate ( Fig. 2A, solid line) . In contrast, when PBS solutions containing 300 M DFP, 300 M edaravone, and 300 M NADH were allowed to stir for 100 h, the oxidation of NADH to NAD ϩ occurred at a higher rate ( Fig. 2A , broken line). When PBS solutions containing oversaturated DFP-E (approximately 200 M) and 1 mM NADH were allowed to stir for 100 h, the oxidation of NADH to NAD ϩ occurred at a considerable rate (Fig. 2B) . It should be noted that, in this reaction, since a sufficient amount of DFP-E was used, the reaction solution was saturated with DFP-E over 100 h, and the concentration of DFP-E was constant throughout this reaction (approximately 200 M).
When PBS solutions containing 300 M 6FP and 300 M NADH were allowed to stir for 100 h, the oxidation of NADH to NAD ϩ did not occur (Fig. 2C, solid line) . In contrast, when PBS solutions containing 300 M 6FP, 300 M edaravone, and 300 M NADH were allowed to stir for 100 h, the oxida- show the oxidation reaction of NADH by DFP alone using PBS solutions containing 300 M DFP and 300 M NADH, which were allowed to stir at pH 7.4. The points (E, DFP; Ⅺ, NADH; ‚, NAD ϩ ) and approximate curves (broken lines) show the oxidation reaction of NADH by the combined use of DFP with edaravone using PBS solutions containing 300 M DFP, 300 M edaravone, and 300 M NADH, which were allowed to stir at pH 7.4. B, reaction of DFP-E with NADH. The points (ϫ, DFP-E; f, NADH; OE, NAD ϩ ) and approximate curves show the oxidation reaction of NADH by DFP-E using PBS solution saturated with DFP-E (approximately 200 M) containing 1 mM NADH, which was allowed to stir at pH 7.4. C, reaction of 6FP and combination of 6FP and edaravone with NADH. The points (F, 6FP; f, NADH; OE, NAD ϩ ) and approximate curves (solid lines) show the oxidation reaction of NADH by 6FP alone using PBS solutions containing 300 M 6FP and 300 M NADH, which were allowed to stir at pH 8.5. The points (E, 6FP; Ⅺ, NADH; ‚, NAD ϩ ) and approximate curves (broken lines) show the oxidation reaction of NADH by the combined use of 6FP with edaravone using PBS solutions containing 300 M 6FP, 300 M edaravone, and 300 M NADH, which were allowed to stir at pH 8.5. In A-C, the concentrations of DFP, DFP-E, 6FP, NADH, and NAD ϩ were measured by RP-HPLC.
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tion of NADH to NAD ϩ occurred at a high rate (Fig. 2C,  broken line) .
O 2 Consumption and ROS Generation. The oxygen concentration of the solution containing 6 mM NADH alone decreased slightly (5% decrease in 100 min Fig. 3A, a) , indicating spontaneous O 2 consumption. In reaction solutions containing 1 mM DFP and 6 mM NADH, an apparent decrease in O 2 concentration was observed (20% decrease in 100 min, Fig. 3A, b) , suggesting conversion of O 2 to ROS. In reaction solutions containing 1 mM DFP, 1 mM edaravone, and 6 mM NADH, the decrease was enhanced (25% decrease in 100 min, Fig. 3A, c) , suggesting that DFP-E was more potent than DFP to convert O 2 to ROS.
To investigate the O 2 -related species generated in the reaction of DFP-E with NADH, the EPR spin trapping technique using DMPO as the spin trap was employed. In this study, PBS, pH 10, was used to facilitate the dissolution of DFP-E. Reaction solutions containing either DFP-E or NADH did not show any EPR signals over 48 h (Fig. 3B, a and b, respectively); however, the reaction solution containing DFP-E and NADH showed oxygen radical signals (Fig.  3B, c) , consisting of a 1:2:2:1 quartet with hyperfine splitting constants of a(N) ϭ 1.49 mT and a(␤H) ϭ 1.49 mT, which is indicative of DMPO-OH (Buettner, 1987) , demonstrating that signals were derived from trapping ⅐ OH. In the presence of ferrous ion (Fe 2ϩ ), ⅐ OH was generated via the iron-catalyzed Fenton reaction from H 2 O 2 (Dunford, 1987) . Furthermore, these signals were quenched by adding catalase (10,000 units/ml) to the reaction solution (Fig. 3B, d ). Based on these observations, it was found that the system composed of DFP-E and NADH finally generated H 2 O 2 from O 2 .
In the cells, although the supernatant obtained from the cells incubated without drugs or with DFP alone did not show any signals (Fig. 3C, a and b, respectively) , the supernatant obtained from the cells incubated with combination of DFP and edaravone showed the DMPO-OH signals (Fig. 3C, c) , which indicated ROS formation in the cells. Furthermore, it was confirmed these signals were quenched by adding catalase (2000 units/ml) to the supernatant (Fig. 3C, d) .
Fluorescence Emission and Uptake of DFP and DFP-E by Cells. In the spectrofluorometric study, when the solution containing either DFP or DFP-E was excited with 360 nm of radiation, they both emitted fluorescence with peak emissions at 480 nm, and the peak fluorescence intensity was almost identical (Fig. 4A) ; therefore, if DFP and DFP-E are taken up by cells to the same extent, they should emit blue fluorescence with almost the same intensity under 360 nm of radiation, and their uptake should be visualized by fluorescent microscopy with a UV filter. However, in the fluorescent microscopic study, emission from cells incubated with DFP and edaravone was much stronger than that with DFP, which indicated that DFP-E was taken up by the cells more than DFP (Fig. 4B) .
Intracellular ROS Generation and Loss of Mitochondrial Membrane Potential Preceding Cell Death. In the time-lapse imaging study using DCFH-DA and TMRM, Panc-1 cells incubated with 200 M DFP and 200 M edaravone showed time-dependent increases in green fluorescence and concomitant decreases in red fluorescence, which indicated intracellular ROS generation and the loss of mitochondrial membrane potential (MMP) preceding cell death (Fig.  5A ). On the other hand, cells incubated with 200 M DFP alone showed increases in green fluorescence to a lesser extent, but the decreases in red fluorescence were not obvious (Fig. 5B) . These findings indicated that intracellular ROS generation occurred but that MMP was maintained in cells incubated with 200 M DFP alone. Furthermore, cells incubated without DFP or edaravone (negative control) exhibited only red fluorescence derived from TMRM but not green fluorescence derived from DCF, which indicated that MMP was maintained with no generation of intracellular ROS (Fig.  5C) .
Effects of Combined Use of DFP with Edaravone on Cell Viability. Cell viability was measured using the MTT Fig. 3 . O 2 consumption and H 2 O 2 generation. A, O 2 consumption in PBS solution containing 6 mM NADH alone (a), 1 mM DFP and 6 mM NADH (b), and 1 mM DFP, 1 mM edaravone, and 6 mM NADH (c). Time course of the changes in oxygen concentration was measured by an oxygen electrode. Oxygen concentration was calibrated with air-saturated PBS, which was assigned as 100%. B, EPR spectra obtained from PBS solution, pH 10, containing 1 mM DFP-E (a), 2 mM NADH (b), 1 mM DFP-E and 2 mM NADH (c), and 1 mM DFP-E, 2 mM NADH, and catalase (10,000 units/ml) (d). C, EPR spectra obtained from the supernatant obtained from the cells incubated without drugs (a), with 400 M DFP alone (b), with combination of 400 M DFP and 400 M edaravone (c), and with combination of 400 M DFP, 400 M edaravone, and catalase (2000 units/ml) (d).
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at ASPET Journals on July 8, 2017 jpet.aspetjournals.org assay. When Panc-1 cells were incubated with combination of 400 M DPF and 400 M edaravone for 1, 2, and 4 h, the cell viability decreased in a time-dependent manner. However, loss of cell viability in the cells incubated for 24 h was almost the same as that in the cells incubated for 4 h (Fig. 6A) . For this reason, the incubation time of this study was set to 4 h in other experiments. The incubation of Panc-1 cells with DFP alone or edaravone alone did not affect cell viability (Fig. 6B, closed and open bars, respectively) , whereas incubation with combination of DFP and edaravone brought decreases in cell viability in a dose-dependent manner (Fig. 6B,  shaded bar) . Significant loss of cell viability was already noticed when more than the combination of 100 M DFP and 100 M edaravone was used. These significant losses of cell viability were attenuated by 10 mM NAC (Fig. 6C) , which indicated that ROS formation was involved in loss of cell viability.
In HUVECs, loss of cell viability by the combined use of DFP with edaravone was also observed, and significant loss was already noticed when the combination of 50 M DFP and 50 M edaravone was used (Fig. 7A, shaded bar) . Furthermore, loss of cell viability was observed in the cells incubated with 400 M DFP alone (Fig. 7A, closed bar) . Loss of viability by the combined use of DFP with edaravone was also observed in hepatocytes, but significant loss was not noticed until the combination of 400 M DFP and 400 M edaravone was used (Fig. 7B, shaded bar) .
Discussion
An authorized free radical scavenger, edaravone, reacted with a pterin derivative DFP, originally developed as a photosensitizer , and immediately produced the reaction product DFP-E. Edaravone is not definitely an ROS generator; however, DFP was shown to generate ROS through NADH oxidation in the previous study (Nonogawa et al., 2007) , and in this study, DFP-E was revealed to react with NADH much more rapidly than DFP and to generate ROS. Because NADH and its analog NADPH are ubiquitous in cell bodies (Nieminen et al., 1997) , an analogous reaction should occur in cells, and DFP-E is considered to generate much more ROS than DFP. Furthermore, it was also revealed that DFP-E is much more cell-permeable than DFP. These conditions collectively account for the intracellular ROS generation and cell death induced by the combined use of DFP with edaravone.
In this study, ROS formation in the reaction of DFP-E and NADH was verified using EPR. EPR is considered to be the least ambiguous method for the detection of free radicals because it allows the identification of original radicals (Buettner, 1987) . The EPR study revealed that detected radicals were ⅐ OH generated via the iron-catalyzed Fenton reaction from H 2 O 2 , which showed that the finally generated ROS was H 2 O 2 . ROS formation in the cells was also verified using EPR, and ⅐ OH derived from H 2 O 2 was detected in the supernatant obtained from the cells incubated with combination of DFP and edaravone. In this case, it was considered that H 2 O 2 generated inside the cells diffused to the supernatant.
Intracellular ROS generation was also observed using time-lapse imaging with the probe DCFH-DA. DCFH-DA permeates cell membranes and becomes DCFH inside the cell. DCFH is then oxidized by ROS to yield DCF, which emits green fluorescence (Royall and Ischiropoulos, 1993) . This probe is widely used to measure intracellular H 2 O 2 formation (Chandel et al., 1998; Simizu et al., 1998) . In a recent study, it was reported that the dihydrocompounds, such as DCFH, are not applicable to the selective detection of individual ROS and that they are suitable for detecting total oxidative activity in living cells (Soh, 2006) . However, DFP-E was demonstrated to chemically react with NADH and finally yield H 2 O 2 in this study, and DFP was also demonstrated to react NADH and yield H 2 O 2 in the previous study (Nonogawa et al., 2007) . Furthermore, H 2 O 2 was detected in No increases in DCF fluorescence in the cells incubated without DFP or edaravone proved that autofluorescence by excitation light, which is problematic in the detection of ROS using DCFH (Rota et al., 1999) , was negligible and that increases in DCF fluorescence certainly reflected intracellular ROS generation.
Cell death was observed using time-lapse imaging with the probe TMRM, which is a fluorescent probe to monitor the MMP. This indicator dye is a lipophilic cation accumulated by mitochondria in proportion to MMP and emits red fluorescence (Scaduto and Grotyohann, 1999) . Discoloration of red fluorescence reflects loss of MMP, which precedes cell Fig. 6 . Effects of combined use of DFP with edaravone on cell viability of Panc-1 cells. A, time-dependent experiments (n ϭ 6). Panc-1 cells were incubated with combination of 400 M DFP and edaravone (DFP&E) for 1, 2, 4, and 24 h. Cells were then washed and incubated for another 24 h, except for the cells incubated with DFP&E for 24 h. Cell viability after 24-h incubation was estimated using the MTT assay. B, dose-dependent experiments (n ϭ 6). Panc-1 cells were incubated with 50 to 400 M DFP alone, 50 to 400 M edaravone alone, or combination of 50 to 400 M DFP and edaravone (DFP&E) for 4 h. Cells were then washed and incubated for another 24 h. Cell viability after 24-h incubation was estimated using the MTT assay. C, effects of NAC on cell viability (n ϭ 6). Panc-1 cells were incubated with combination of 100 to 400 M DFP and edaravone (DFP&E) in the absence or presence of 10 mM NAC for 4 h. Cells were then washed and incubated for another 24 h. Cell viability after 24-h incubation was estimated using the MTT assay. Cell viability is shown as a percentage and that obtained from jpet.aspetjournals.org death (Kon et al., 2004) . In Panc-1 cells incubated with 200 M DFP and 200 M edaravone, the discoloration occurred in inverse proportion to the appearance and increment of green fluorescence; however, in Panc-1 cells incubated with 200 M DFP alone, although increases in green fluorescence was observed, discoloration of red fluorescence was not obvious. Therefore, ROS generation is considered not to necessarily cause the loss of MMP, and the amount of ROS may concern the loss of MMP preceding cell death.
Cell viability was measured using the MTT assay, which reflects cellular growth and survival (Mosmann, 1983) . When Panc-1 cells were incubated with combination of DFP and edaravone for 4 h and then washed out and incubated without drugs for another 24 h, cell viability decreased significantly in cells incubated with more than 100 M DFP and 100 M edaravone. Because the loss of MMP preceding cell death were observed in cells incubated with combination of DFP and edaravone in the time-lapse imaging study, the reduction of cell viability was caused by the blocking of cellular survival; therefore, a large amount of ROS generated by the combined use of DFP with edaravone is considered to cause cell death. The fact that NAC, an antioxidant, attenuated the cell death supported this idea. DFP alone induced intracellular ROS generation to some extent, but significant decreases in cell viability were not observed in Panc-1 cells incubated with even a high dose of DFP alone (400 M). However, in HUVECs, a low dose of DFP and edaravone (50 M, in each) and a high dose of DFP alone (400 M) caused significant decreases in cell viability. In contrast, in hepatocytes, significant decreases in cell viability were not observed until a high dose of DFP and edaravone (400 M, in each) was applied. These results indicated that cellular survival depends on the amount of generated ROS and the resistance of each type of cell against intracellular ROS. In the case of hepatocytes, cells may decompose DFP-E by metabolism or may quench ROS more vigorously with intrinsic antioxidants, such as glutathione, than other types of cells. In this study, seeding densities were different among three types of cell, which may have affected the resistance against ROS. However, proper culture condition was chosen for each type of cell (approximately 80% confluent in each medium), and cell viability seems to reflect the resistance of each type of cell against ROS to some extent. Further study will be required to elucidate this issue.
Edaravone reacted with not only DFP but also 6FP, and the reaction product should generate ROS through NADH oxidation. DFP is a synthesized compound and does not naturally exist in the body; however, 6FP is produced from folic acid in vivo in some pathological conditions, such as carcinoma (Halpern et al., 1977; Clynes and O'Neill, 1980; Durán et al., 1984) and possibly exists in the body. It was reported that 6FP was found in the urine at approximately 300 M or greater in patients with a tissue diagnosis of cancer (Halpern et al., 1977) , and the plasma concentration of edaravone in clinical cases is estimated around 10 M (Group, 2003) . This indicates the possibility that edaravone reacts with pterin derivatives existing in the body, such as 6FP, and yields ROS-generating compounds, which may induce cell death in vital organs. In Japan, edaravone was used in 140,000 patients per year since 2001, and it was reported that 12 patients died from acute renal failure in 2002 and that one patient died from fulminant hepatitis in 2004 (information from Ministry of Health Labor and Welfare of Japan). These severe side effects of edaravone may be induced by this mechanism. Therefore, care should be taken with the clinical use of edaravone when pterin derivatives remain in the body.
On the other hand, the cell-destructive nature of the combined use of DFP with edaravone is attractive from the standpoint of anticancer therapy. First, its ability to kill Panc-1 cells is powerful. Pancreatic cancer remains an unfortunate disease with a 5-year survival rate below 1% (Keleg et al., 2003) . Second, tumoricidal activity was not exhibited until both agents were administered, at which point they worked at once in situ. Third, hepatocytes were considerably resistant against cell injury induced by the combined use of DFP with edaravone, which indicated the possibility of DFP-E detoxication by the liver. Although the intolerance of HUVECs against the combined use of DFP with edaravone is unfavorable, the drug delivery device may overcome this point.
In conclusion, the reaction product of DFP-E was much more cell-permeable and generated much more ROS inside cells than DFP. This conceivably explains why the combined use of DFP with edaravone induced cell death at low doses despite no cell death by the single use of DFP. This is unfavorable as a side effect but favorable as tumoricidal activity. Because edaravone is a clinically available agent, its adverse and advantageous effects should be further investigated.
